EP
PerMed News |
|
16
March 2026  New
Best Practice: National Paediatric Screening of Familial
Hypercholesterolemia in Luxembourg
EP
PerMed awardes the title of 'Best Practice' (BP) in
Personalised Medicine to the national paediatric
screening programme of familial hypercholesterolemia in
Luxembourg as an example of successful implementation of
a personalised prevention. The programme was launched in
November 2025 and is part of a broader European
initiative aimed at improving early detection and
management of familial hypercholesterolemia through
systematic paediatric screening.
Read more |
|
13
March 2026 
EP
PerMed Podcast receives Life Science Excellence Award as
‘Best Communication Project of the Year’
The
EP PerMed podcast, ‘The Science of You’, won the Life
Science Excellence Award in the ‘Best Commucation
Project of the Year’ category. The award ceremony took
place in Milan last week during the Innovation Festival,
promoted by Homnya. The award recognises outstanding and
innovative projects in the fields of research, education
and scientific communication in the life sciences that
are designed for patients or clinicians.
Read more |
|
12 March 2026 
New
Podcast Episode: the Story of Olivia and Dianne, whose
Hearts have been protected since Childhood
In
the latest episode of our podcast, Dutch teenagers
Olivia and Dianne share their lived experience with a
rare, life‑threatening cholesterol disorder. Recorded
live at the ICPerMed and EP PerMed Conference in Prague,
they join FH Europe’s Magdalena Daccord to discuss how
early diagnosis and cutting‑edge personalised therapies
have transformed a once‑invasive treatment journey into
a peaceful, normal life.
Read more |
|
11
March 2026 
EP
PerMed Hackathon – the Use of non-invasive Biomarkers
within Personalised Medicine Approaches
From
3 to 4 March 2026, Oostende (Belgium) was the stage for
the first edition of the EP PerMed hackathon focusing on
personalised medicine. More than 100 participants from
17 different countries spent two days intensively
developing their innovative solutions and ideas.
Read more |
|
06 March 2026 
Personalising
Treatment for Europe’s most common Leukaemia - new
Sucess Story published
Chronic
lymphocytic leukaemia (CLL) is the most common form of
leukaemia in Europe, and despite significant medical
advances, it remains incurable. The CLL-CLUE project
utilised Functional Precision Medicine (FPM) to improve
the treatment outcome of CLL. The consortium used a
specific targeted drug (a PI3K inhibitor) as a model to
understand how these therapies change the internal
communication lines, or cell signaling, within leukaemia
cells.
Read more |
|
20 February 2026 
Video
Interviews from the joint ICPerMed & EP PerMed
Conference
While
we were in Prague for the joint ICPerMed and EP PerMed
conference, we took the opportunity to interview some of
our speakers, as well as international experts and
stakeholders. We discussed the advancements made in the
implementation of personalised medicine over the last
decade. You can now find all the interviews on the EP
PerMed website and on our YouTube channel.
Read more |
|
17 February
2026 
FAQs
for the Twinning Call 2026
A
new FAQ document has been published to support the
development of proposals for the EP PerMed Twinning Call
2026, answering the most common questions relating to
it.
Read more |
|
13 February
2026 
ERA
PerMed JTC2022 Midterm Symposium: Prevention in
Personalised Medicine
The
ERA PerMed JTC2022 Midterm Symposium, held on 3–4
February 2026 in Paris, brought together researchers,
clinicians, funders, and patient engagement experts to
discuss the progress and interim outcomes of projects
funded under the ERA PerMed Joint Transnational Call
2022.
Read more |
|
13 February
2026 
EP
PerMed Training in Data Management in Personalised
Medicine
On
the 5th and 6th of February 2026, EP PerMed organised a
two-day, fully in-person Training on Data Management at
the offices of ANR, in Paris, held back-to-back with the
ERA PerMed JTC2022 midterm seminar.
Read more |
|
06 February
2026 
Deadline
extended! Call for Tender on Surveys 2026 – Assessment
and Analysis of Genetic Testing
EP
PerMed launched its first Call for Tender on Surveys and
invites suitable stakeholders to apply. The topic of the
tender is the assessment and analysis of genetic testing
related to personalised medicine approaches for
different countries and health systems.
Read more |
|
05 February 2026 
New
Best Practice Example: Genetics-based Personalised
Breast Cancer Prevention and Screening
EP
PerMed awardes the title of “Best Practice” (BP) in
Personalised Medicine to the ‘Genetics-based
Personalised Breast Cancer Prevention and Screening’
project. Currently utilised in the private healthcare
sectors of several European countries, the service will
be implemented in Estonia in 2026 as a national
polygenic risk score (PRS)-based personalised breast
cancer screening programme.
Read more |
|
03 February
2026 
Fast
Track Validation Programme 2026 – Webinar Recording
available
EP
PerMed organised a webinar to go through the EP PerMed
Fast Track Call 2026 and answer any question about the
call, the application process on 20 January 2026. The
slides and recording are now available.
Read more |
|
19 January 2026 
EP
PerMed JTC2025 Results: Funding provided for 22
transnational Projects on Personalised Medicine
EP
PerMed will fund 22 new research projects with around
€34.4 million under its Joint Transnational Call 2025
“Pharmacogenomic Strategies for Personalised Medicine
Approaches (PGxPM2025)”. The 22 projects will involve
more than 140 research groups from 24 countries and
European regions.
Read more |
|
19 January 2026 
EP
PerMed in-situ Visit at the Center for Precision
Medicine in Brno – Report available
EP
PerMed organised an in-suto visit to the Center for
Precision Medicine of the University Brno (Czech
Republic) on 27 and 28 November 2025, back-to-back with
the first joint ICPerMed and EP PerMed Conference in
Prague. The report on the visit is now available.
Read more |
Other
PM-related News |
|
17 March 2026 
Survey
on Genomic Medicine Training for Healthcare
Professionals
For
the widespread implementation of genomics in healthcare
to benefit patients and improve the efficiency of health
services, adequate training of health professionals in
genomic medicine is key. To this end, the Genomic Data
Infrastructure (GDI) project has developed an
international survey on genomic medicine training for
healthcare professionals.
Read more |
|
06 March 2026 
White
Paper on Advancing Precision Oncology Treatment and
Testing across Europe
The
European Federation of Pharmaceutical Industries and
Associations (EFPIA) has published the white paper
“Advancing precision oncology treatment and testing
across Europe: An evidence-based roadmap for healthcare
system stakeholders to improve cancer care”.
Read more |
|
04 March 2026 
EMA
Consultation on the Guideline Revision on Good
Pharmacogenomic Practice
The
European Medicines Agency (EMA) has opened an an online
consultation on its concept paper on the revision of the
guideline on good pharmacogenomic practice.
Read more |
|
26 February 2026 
ICPerMed Webinar
- the 2025 French Genomic Medicine Initiative
In
the frame of the ICPerMed Strategic Working Group on
Internationalisation, a webinar was organised on 26
February 2026. Dr Frédérique Nowak, deputy coordinator,
presented the 2025 French Genomic Medicine Initiative
and its future perspective. A recording of the webinar
is available.
Read more |
|
See all news |
Open
Calls
Call for Tender on Surveys
2026 |
Events |
|
26
March 2026 - Patients’ rights on cross-border
healthcare and the European Reference Networks
26
- 27 March 2026 - PROPHET - Event on Personalised
Prevention
11 - 12
May 2026 - Precision Medicine Forum Europe
2026
19 - 22
May 2026 - Europe Biobank Week
14 - 16 September
2026 - Nordic Conference on Future of
Health |
|
See all events
|
